InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Chadha Deepak, Directeur de la Recherche et du Développement. Director active across 3 companies, notably Brickell Biotech, Inc.. In total, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €2k. Activity tracked since 18 May 2021. The latest transaction was disclosed on 18 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Chadha Deepak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
35,000 股Common StockSEC:0001628280-23-041230:0
2,700 股@ US$0.8191100.0% 占其流量Common StockSEC:0001062993-21-004866:0
标准退出：2021年8月16日 (T+90)
2 条申报中的 2 条
About Chadha Deepak
Deepak Chadha is the Chief Research & Development Officer at Brickell Biotech, Inc. He is responsible for innovation and the development of new products within the company.
